COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,100 Articles (22,658 medRxiv, 8,442 bioRxiv)

Most recent first Previous |  Page 382: Articles 3811-3820  | Next

The effect of residential aged care facility COVID-19 lockdowns on resident mortality
Uribe, M. G., Fotheringham, P., Moore, C. B.
10.1101/2023.06.26.23291907 — Posted: 2023-06-28
COVID-19 Impact in Crohn Disease Patients Underwent Autologous Hematopoietic Stem Cell Transplantation
RUIZ, M. A., Kaiser Junior, R. L., Piron-Ruiz, L., Pinho, T. S., Castiglioni, L., De Quadros, L. G.
10.1101/2023.06.22.23291610 — Posted: 2023-06-28
SARS-CoV-2 testing in the Slovak Republic from March 2020 to September 2022 - summary of the pandemic trends
Janostiakova, N., Gnip, A., Kodada, D., Saade, R., Blandova, G., Mikova, E., Tibenska, E., Repiska, V., Minarik, G.
10.1101/2023.06.26.23291891 — Posted: 2023-06-28
Targeting Multiple Conserved T-Cell Epitopes for Protection against COVID-19 Moderate-Severe Disease by a Pan-Sarbecovirus Vaccine
Wang, C. Y., Kuo, B.-S., Lee, Y.-H., Ho, Y.-H., Pan, Y.-H., Yang, Y.-T., Chang, H.-C., Fu, L.-F., Peng, W.-J.
10.1101/2023.06.28.23291948 — Posted: 2023-06-28
A human primary airway microphysiological system infected with SARS-CoV-2 distinguishes the treatment efficacy between nirmatrelvir and repurposed compounds fluvoxamine and amodiaquine
Lopez Quezada, L., Mba Medie, F., Gabriel, E. P., Luu, R. J., Rubio, L. D., Mulhern, T. J., Borenstein, J. T., Fisher, C. R., Gard, A. L.
10.1101/2023.06.27.546790 — Posted: 2023-06-28
Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potential
Martinez, D. R., Moreira, F., Zweigart, M. R., Gully, K. L., De la Cruz, G., Brown, A., Adams, L. E., Catanzaro, N., Yount, B., Baric, T. J., Mallory, M., Conrad, H., May, S. R., Dong, S., Scobey, T. D., Montgomery, S., Perry, J. K., Babusis, D., Barrett, K., Nguyen, A.-H., Nguyen, A.-Q., Kalla, R., Bannister, R., Bilello, J., Feng, J., Cihlar, T., Baric, R. S., Mackman, R., Schaefer, A., Sheahan, T. P.
10.1101/2023.06.27.546784 — Posted: 2023-06-28
Infoveillance study on the dynamic associations between CDC social media contents and epidemic measures during COVID-19
Yin, S., Chen, S., Ge, Y.
10.1101/2023.06.26.23291921 — Posted: 2023-06-27
SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy
Edelstein, G. E., Boucau, J., Uddin, R., Marino, C., Liew, M. Y., Barry, M., Choudhary, M. C., Gilbert, R. F., Reynolds, Z., Li, Y., Tien, D., Sagar, S., Vyas, T. D., Kawano, Y., Sparks, J. A., Hammond, S. P., Wallace, Z., Vyas, J. M., Barczak, A. K., Lemieux, J. E., Li, J. Z., Siedner, M. J.
10.1101/2023.06.23.23288598 — Posted: 2023-06-27
Follow-Up In Patients With Respiratory Disability After ARDS Related To COVID-19: A Systematic Review
Triantafyllaki, P., Charalampopoulos, M., Sampani, C.-A., Triantafyllou, C., Papageorgiou, D.
10.1101/2023.06.24.23291855 — Posted: 2023-06-27
Spatial and temporal clustering of anti-SARS-CoV-2 antibodies in Illinois household cats, 2021- 2023
Chen, C., Martins, M., Yettapu, D., Diel, D., Jennifer, R., Urbasic, A., Robinson, H., Varga, C., Fang, Y.
10.1101/2023.06.21.23291564 — Posted: 2023-06-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).